Cargando…
Metabolism‐based therapies for epilepsy: new directions for future cures
OBJECTIVE: Thousands of years after dietary therapy was proposed to treat seizures, how alterations in metabolism relates to epilepsy remains unclear, and metabolism‐based therapies are not always effective. METHODS: We consider the state of the science in metabolism‐based therapies for epilepsy acr...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8351378/ https://www.ncbi.nlm.nih.gov/pubmed/34247456 http://dx.doi.org/10.1002/acn3.51423 |
_version_ | 1783735961748766720 |
---|---|
author | Cervenka, Mackenzie Pascual, Juan M. Rho, Jong M. Thiele, Elizabeth Yellen, Gary Whittemore, Vicky Hartman, Adam L. |
author_facet | Cervenka, Mackenzie Pascual, Juan M. Rho, Jong M. Thiele, Elizabeth Yellen, Gary Whittemore, Vicky Hartman, Adam L. |
author_sort | Cervenka, Mackenzie |
collection | PubMed |
description | OBJECTIVE: Thousands of years after dietary therapy was proposed to treat seizures, how alterations in metabolism relates to epilepsy remains unclear, and metabolism‐based therapies are not always effective. METHODS: We consider the state of the science in metabolism‐based therapies for epilepsy across the research lifecycle from basic to translational to clinical studies. RESULTS: This analysis creates a conceptual framework for creative, rigorous, and transparent research to benefit people with epilepsy through the understanding and modification of metabolism. INTERPRETATION: Despite intensive past efforts to evaluate metabolism‐based therapies for epilepsy, distinct ways of framing a problem offer the chance to engage different mindsets and new (or newly applied) technologies. A comprehensive, creative, and inclusive problem‐directed research agenda is needed, with a renewed and stringent adherence to rigor and transparency across all levels of investigation. |
format | Online Article Text |
id | pubmed-8351378 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-83513782021-08-15 Metabolism‐based therapies for epilepsy: new directions for future cures Cervenka, Mackenzie Pascual, Juan M. Rho, Jong M. Thiele, Elizabeth Yellen, Gary Whittemore, Vicky Hartman, Adam L. Ann Clin Transl Neurol Point of View OBJECTIVE: Thousands of years after dietary therapy was proposed to treat seizures, how alterations in metabolism relates to epilepsy remains unclear, and metabolism‐based therapies are not always effective. METHODS: We consider the state of the science in metabolism‐based therapies for epilepsy across the research lifecycle from basic to translational to clinical studies. RESULTS: This analysis creates a conceptual framework for creative, rigorous, and transparent research to benefit people with epilepsy through the understanding and modification of metabolism. INTERPRETATION: Despite intensive past efforts to evaluate metabolism‐based therapies for epilepsy, distinct ways of framing a problem offer the chance to engage different mindsets and new (or newly applied) technologies. A comprehensive, creative, and inclusive problem‐directed research agenda is needed, with a renewed and stringent adherence to rigor and transparency across all levels of investigation. John Wiley and Sons Inc. 2021-07-11 /pmc/articles/PMC8351378/ /pubmed/34247456 http://dx.doi.org/10.1002/acn3.51423 Text en © 2021 The Authors. Annals of Clinical and Translational Neurology published by Wiley Periodicals LLC on behalf of American Neurological Association. This article has been contributed to by US Government employees and their work is in the public domain in the USA https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
spellingShingle | Point of View Cervenka, Mackenzie Pascual, Juan M. Rho, Jong M. Thiele, Elizabeth Yellen, Gary Whittemore, Vicky Hartman, Adam L. Metabolism‐based therapies for epilepsy: new directions for future cures |
title | Metabolism‐based therapies for epilepsy: new directions for future cures |
title_full | Metabolism‐based therapies for epilepsy: new directions for future cures |
title_fullStr | Metabolism‐based therapies for epilepsy: new directions for future cures |
title_full_unstemmed | Metabolism‐based therapies for epilepsy: new directions for future cures |
title_short | Metabolism‐based therapies for epilepsy: new directions for future cures |
title_sort | metabolism‐based therapies for epilepsy: new directions for future cures |
topic | Point of View |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8351378/ https://www.ncbi.nlm.nih.gov/pubmed/34247456 http://dx.doi.org/10.1002/acn3.51423 |
work_keys_str_mv | AT cervenkamackenzie metabolismbasedtherapiesforepilepsynewdirectionsforfuturecures AT pascualjuanm metabolismbasedtherapiesforepilepsynewdirectionsforfuturecures AT rhojongm metabolismbasedtherapiesforepilepsynewdirectionsforfuturecures AT thieleelizabeth metabolismbasedtherapiesforepilepsynewdirectionsforfuturecures AT yellengary metabolismbasedtherapiesforepilepsynewdirectionsforfuturecures AT whittemorevicky metabolismbasedtherapiesforepilepsynewdirectionsforfuturecures AT hartmanadaml metabolismbasedtherapiesforepilepsynewdirectionsforfuturecures |